Topline Capital Partners, LP - 09 Nov 2022 Form 4 Insider Report for Usio, Inc. (USIO)

Reporting relationship: 10%+ Owner
Issuer ticker: USIO
Reported as of: 09 Nov 2022
Net transaction value: -$1,051,090
SEC form: 4
Accepted by SEC: 14 Nov 2022, 16:39:50 UTC
Prior SEC filing: 21 Oct 2022
Next SEC filing: 21 Dec 2022
Source filing: View source filing
Reporting owner signature: Topline Capital Partners, LP By: Topline Capital Management, LLC, the general partner By: Collin McBirney, its Managing Member

Key filing fact

Topline Capital Partners, LP filed Form 4 for Usio, Inc. (USIO) on 14 Nov 2022.

Key facts

This page summarizes Topline Capital Partners, LP's Form 4 filing for Usio, Inc. (USIO).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 14 Nov 2022, 16:39.

Change

Previous filing in this sequence was filed on 21 Oct 2022.
Current net transaction value: -$1,051,090.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

USIO transaction

Common Stock

Sale

Transaction value: $237,392
Shares: -112,508
Change %: -3.8%
Price: $2.11
Shares after: 2,825,435
Date: 09 Nov 2022
Ownership: Direct

USIO transaction

Common Stock

Sale

Transaction value: $77,188
Shares: -39,994
Change %: -1.4%
Price: $1.93
Shares after: 2,785,441
Date: 10 Nov 2022
Ownership: Direct

USIO transaction

Common Stock

Sale

Transaction value: $736,510
Shares: -357,529
Change %: -13%
Price: $2.06
Shares after: 2,427,912
Date: 11 Nov 2022
Ownership: Direct

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .